Report: WHO Strategic Priorities on Antimicrobial Resistance
24 May 2022
Antimicrobial resistance (AMR) poses a significant global threat of far-reaching proportions. It is estimated that drugresistant infections contribute to nearly 5 million deaths every year.
Unless we act now, common diseases will become untreatable and modern life-saving procedures riskier to perform. The economic impact of uncontrolled antimicrobial resistance will result in a dramatic rise in health expenditures and damage to food systems and livelihoods, leading to increasing levels of poverty
and inequality.
Further reading: WHO
Author(s): WHO
Clean Environment Effective Surveillance Healthy Animals Healthy Patients Secure Foods Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!